Phospho-IKBKG (S31) Antibody

What is Phospho-IKBKG (S31) Antibody and what is its target?

Phospho-IKBKG (S31) Antibody is a rabbit polyclonal antibody that specifically detects the IKBKG protein (also known as IKK-gamma or NEMO) only when phosphorylated at Serine 31. IKBKG functions as the regulatory subunit of the IκB kinase (IKK) complex, which plays a crucial role in activating NF-κB in response to various stimuli. The antibody typically recognizes a synthetic phosphopeptide derived from human IKBKG around the phosphorylation site of Serine 31, with the sequence containing E-E-S(p)-P-L amino acids .

What are the common applications for Phospho-IKBKG (S31) Antibody?

Phospho-IKBKG (S31) Antibody is validated for multiple applications including Western Blot (WB), Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry (IHC), and Immunofluorescence (IF) . In Western blot applications, the antibody detects a protein with a molecular weight of approximately 48 kDa . These various applications make the antibody versatile for detecting phosphorylated IKBKG in different experimental contexts, from protein expression analysis to cellular localization studies.

What are the recommended storage conditions for Phospho-IKBKG (S31) Antibody?

Phospho-IKBKG (S31) Antibody should be stored at -20°C or -80°C upon receipt . To maintain antibody stability and activity, it's crucial to avoid repeated freeze-thaw cycles, which can lead to protein denaturation and loss of antibody specificity . Many commercial preparations contain stabilizers such as glycerol (typically 50%), BSA (0.5%), and sodium azide (0.02%) to help maintain antibody integrity during storage .

What are the optimal dilution ratios for different applications?

The recommended dilution ratios vary by application type:

• Western Blot: 1:500-1:2000 or 1:500-1:1000

• Immunohistochemistry: 1:100-1:300

• Immunofluorescence: 1:50-1:200

• ELISA: 1:10000

These ratios should be considered starting points, and optimization may be necessary depending on sample type, detection method, and signal strength requirements. Pilot experiments with different dilutions are recommended to determine optimal conditions for specific experimental setups.

How should I prepare samples to maximally preserve phosphorylation at Serine 31?

To preserve phosphorylation status, samples should be collected and processed with phosphatase inhibitors (such as sodium fluoride, sodium orthovanadate, and β-glycerophosphate) in all buffers. Cell lysis should be performed quickly on ice to minimize dephosphorylation. When studying IKBKG phosphorylation kinetics, rapid sample collection and flash-freezing after stimulation are critical. Additionally, reducing the time between sample preparation and analysis helps maintain phosphorylation integrity, and for Western blot applications, sample boiling time should be minimized.

How can I verify the specificity of Phospho-IKBKG (S31) Antibody in my experiments?

Several approaches can verify antibody specificity:

• Phosphatase treatment control: Treating half your sample with lambda phosphatase should eliminate signal from a true phospho-specific antibody

• Peptide competition assay: Pre-incubating the antibody with phosphorylated peptide should block specific binding

• Knockout/knockdown validation: Using IKBKG knockout or knockdown samples as negative controls

• Phosphorylation induction: Comparing samples with induced phosphorylation (e.g., TNF-α stimulation) versus unstimulated controls

These validation steps are particularly important since phospho-specific antibodies can sometimes recognize similar phosphorylated motifs on other proteins .

What controls should be included when using Phospho-IKBKG (S31) Antibody?

A robust experimental design should include multiple controls:

• Positive control: Lysates from cells treated with known IKBKG phosphorylation inducers (TNF-α, IL-1β)

• Negative control: Unstimulated cells or phosphatase-treated samples

• Loading control: Detection of total IKBKG protein to normalize phospho-signal

• Non-specific binding control: Secondary antibody-only sample

• Cross-reactivity control: When possible, IKBKG-deficient cells

These controls help distinguish specific signal from background and enable accurate quantification of relative phosphorylation levels across experimental conditions.

How can Phospho-IKBKG (S31) Antibody be used to study NF-κB pathway dynamics?

For studying NF-κB pathway dynamics, researchers can employ time-course experiments measuring IKBKG phosphorylation at Ser31 following stimulation with pathway activators like TNF-α or IL-1β. The antibody can be incorporated into multiplexed Western blots or immunofluorescence studies to simultaneously detect multiple phosphorylation events (e.g., IKKα/β, IκBα) and correlate them with downstream transcription factor activation. This approach provides insights into temporal relationships between different phosphorylation events in the signaling cascade. For more sophisticated analyses, researchers can combine phospho-IKBKG detection with proximity ligation assays to visualize protein-protein interactions dependent on this phosphorylation event.

What are approaches for measuring IKBKG phosphorylation kinetics in living cells?

While direct measurement of IKBKG phosphorylation in living cells remains challenging, several indirect approaches can be employed:

• FRET-based biosensors: Engineered constructs containing the IKBKG phosphorylation site between appropriate fluorophores

• Time-resolved immunoprecipitation: Sequential sample collection followed by immunoprecipitation with Phospho-IKBKG (S31) Antibody

• Split luciferase complementation assays: Detection of phosphorylation-dependent protein interactions

• Mass spectrometry with SILAC: Quantitative assessment of phosphorylation dynamics

These methods provide complementary information about the temporal regulation of IKBKG phosphorylation and its downstream consequences.

How can I distinguish between different IKBKG phosphorylation sites in my research?

IKBKG contains multiple phosphorylation sites beyond Ser31, including Ser43, Ser68, and Ser85. To distinguish between these modifications:

• Use site-specific phospho-antibodies for each site of interest in parallel experiments

• Employ phospho-site mutants (S31A, etc.) in rescue experiments

• Conduct mass spectrometry analysis to identify all phosphorylation sites simultaneously

• Use phospho-site specific inhibitors when available

Comprehensive analysis requires both detection of specific phosphorylation events and functional studies to determine their biological significance in your experimental system.

What are common causes for weak or absent signal when using Phospho-IKBKG (S31) Antibody?

Several factors can contribute to weak or absent signals:

• Rapid dephosphorylation: Inadequate phosphatase inhibitors during sample preparation

• Insufficient stimulation: Suboptimal conditions for inducing Ser31 phosphorylation

• Antibody degradation: Improper storage or excessive freeze-thaw cycles

• Low protein concentration: Insufficient starting material or protein loss during processing

• Blocking interference: Overly stringent blocking conditions affecting antibody binding

• Detection sensitivity: Suboptimal secondary antibody or detection reagents

Troubleshooting should begin with positive controls and systematic evaluation of each experimental step, from stimulation conditions to detection methods.

How can I optimize Western blot protocols specifically for Phospho-IKBKG (S31) detection?

Optimal Western blot protocols for phospho-protein detection require special considerations:

• Transfer optimization: Use PVDF membranes for higher protein binding capacity

• Blocking optimization: Test BSA-based blockers which sometimes perform better than milk for phospho-epitopes

• Primary antibody incubation: Extended incubation (overnight at 4°C) at optimized dilution

• Buffer composition: Include phosphatase inhibitors in all buffers

• Enhanced detection: Consider using signal enhancement systems for low-abundance phospho-proteins

• Stripping precautions: If reprobing is necessary, use gentle stripping conditions to preserve phospho-epitopes

These optimizations help maximize sensitivity while maintaining specificity for the phosphorylated form of IKBKG.

How should I interpret data when total IKBKG and phospho-IKBKG (S31) signals don't correlate?

Discrepancies between total and phospho-IKBKG signals can result from several biological phenomena:

• Stimulus-dependent phosphorylation affecting only a subset of total IKBKG

• Subcellular relocalization of phosphorylated IKBKG to detergent-resistant compartments

• Phosphorylation-induced conformational changes affecting antibody accessibility

• Phosphorylation-dependent protein-protein interactions masking epitopes

• Differential stability of phosphorylated versus non-phosphorylated forms

Proper interpretation requires considering these potential mechanisms and implementing additional experiments to distinguish between them, such as subcellular fractionation or co-immunoprecipitation studies.

How does IKBKG (S31) phosphorylation relate to other post-translational modifications on this protein?

IKBKG undergoes multiple post-translational modifications beyond Ser31 phosphorylation, including phosphorylation at other sites, ubiquitination, and SUMOylation. Particularly important is the relationship between phosphorylation at Ser31 and Ser68, where Ser68 phosphorylation attenuates aminoterminal homodimerization . Additionally, IKBKG is polyubiquitinated on Lys-285 via 'Lys-63'-linked ubiquitin chains, mediated downstream of NOD2 and RIPK2, which facilitates interactions with ubiquitin domain-containing proteins and activates the NF-kappa-B pathway . Understanding the interplay between these modifications requires sophisticated experimental approaches, including sequential immunoprecipitation and mass spectrometry analysis.

What are appropriate methods for quantifying relative phosphorylation levels across experimental conditions?

Quantification of phosphorylation requires normalization strategies:

• Ratio method: Calculate phospho-IKBKG signal relative to total IKBKG

• Loading control normalization: Normalize both phospho and total signals to housekeeping proteins

• Internal reference: Include a standard sample across all blots for inter-experimental normalization

• Densitometric analysis: Use linear range of detection for accurate quantification

• Multiplexed detection: When possible, detect phospho and total proteins simultaneously

Statistical analysis should account for the non-linear nature of many detection methods and consider using log-transformation before applying parametric tests.

Can Phospho-IKBKG (S31) Antibody be used for immunoprecipitation of the phosphorylated protein?

While general information about immunoprecipitation capabilities is not explicitly stated in the search results, phospho-specific antibodies can often be used for immunoprecipitation of the phosphorylated form of their target proteins. For optimal results in immunoprecipitation:

• Use higher antibody concentrations than for Western blotting

• Maintain phosphatase inhibitors throughout the procedure

• Optimize binding conditions (temperature, time, buffer composition)

• Consider crosslinking the antibody to beads to prevent interference from heavy/light chains

• Validate specificity by Western blotting the immunoprecipitated material

Successful immunoprecipitation enables studies of phosphorylation-dependent protein interactions and additional post-translational modifications.

How can Phospho-IKBKG (S31) Antibody be incorporated into high-throughput screening approaches?

Phospho-IKBKG (S31) Antibody can be adapted for high-throughput applications through:

• ELISA-based screening: Developing 96/384-well plate formats for rapid testing of compounds affecting IKBKG phosphorylation

• Automated immunofluorescence: Using image-based high-content screening to assess phosphorylation in cellular context

• Reverse phase protein arrays: Analyzing phospho-IKBKG across large sample collections

• Bead-based multiplexed assays: Developing Luminex-type assays for simultaneous detection of multiple phosphorylation events

These approaches facilitate drug discovery efforts targeting the NF-κB pathway and personalized medicine applications examining pathway activation in patient samples.

What considerations are important when designing experiments to study the functional consequences of IKBKG Ser31 phosphorylation?

To establish causal relationships between Ser31 phosphorylation and functional outcomes:

• Generate phospho-mimetic (S31D/E) and phospho-deficient (S31A) mutants

• Use CRISPR-Cas9 to create knockin cell lines expressing these mutants endogenously

• Employ selective IKK inhibitors with differential effects on Ser31 phosphorylation

• Develop temporal control systems (e.g., optogenetic approaches) to manipulate phosphorylation dynamics

• Combine phosphorylation detection with functional readouts (gene expression, chromatin modification)

These experimental designs help distinguish the specific contributions of Ser31 phosphorylation from other regulatory mechanisms affecting IKBKG function.

How might single-cell analysis techniques be applied to study heterogeneity in IKBKG phosphorylation?

Single-cell approaches provide insights into cell-to-cell variability in signaling:

• Single-cell Western blotting: Emerging technologies enabling protein analysis at single-cell resolution

• Mass cytometry (CyTOF): Developing metal-conjugated phospho-IKBKG antibodies for high-dimensional analysis

• Imaging mass spectrometry: Spatial analysis of phosphorylation events in tissue context

• Single-cell sequencing with protein analysis: Correlating phosphorylation status with transcriptional output

These technologies help address questions about how cellular heterogeneity in phosphorylation contributes to diverse functional outcomes within cell populations responding to the same stimulus.

How does antibody-based detection of phospho-IKBKG compare with mass spectrometry approaches?

Both techniques offer complementary advantages:

Integrating both approaches provides the most comprehensive understanding of IKBKG phosphorylation dynamics and stoichiometry.

What strategies can be used to correlate IKBKG Ser31 phosphorylation with downstream functional outcomes?

Multi-level analysis approaches include:

• Temporal correlation studies: Time-course experiments measuring phosphorylation and downstream events

• Pharmacological perturbation: Using specific kinase/phosphatase inhibitors to manipulate phosphorylation

• Genetic approaches: Comparing wild-type with phospho-mutant IKBKG expression systems

• Pathway reconstruction: In vitro reconstitution with purified components to establish direct causality

• Systems biology modeling: Computational integration of phosphorylation data with downstream responses

These approaches help establish not just correlation but mechanistic links between Ser31 phosphorylation and biological outcomes.

How can molecular dynamics simulations complement experimental studies of IKBKG phosphorylation?

Computational approaches provide structural insights:

• Conformational changes: Simulating structural alterations induced by Ser31 phosphorylation

• Protein-protein interactions: Predicting how phosphorylation affects binding interfaces

• Electrostatic effects: Calculating changes in local electrostatic potential upon phosphorylation

• Molecular recognition: Modeling how phospho-binding domains might recognize phosphorylated IKBKG

• Allosteric effects: Identifying long-range conformational changes propagated from the phosphorylation site